Neonatal lupus syndrome: Review of the literature;«lupus néonatal»: Revue de la littérature

Revue de Medecine Interne

Volumn 24, Issue 10, 2003, Pages 659-671

  Costedoat Chalumeau, N ^a   Amoura, Z ^a   Le Thi Hong, D ^a   Georgin, S ^a   Vauthier, D ^a   Sebbouh, D ^a   Frances C ^a   Villain, E ^b   Wechsler, B ^a   Piette, J C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Anti La SSB antibodies; Anti Ro SSA antibodies; Congenital heart block; Gougerot Sj gren; Neonatal lupus erythematosus; Systemic lupus erythematosus

Indexed keywords

BETAMETHASONE; CORTICOSTEROID; FLUORINATED STEROID; MATERNAL ANTIBODY;

ARTIFICIAL HEART PACEMAKER; CLINICAL FEATURE; CONGENITAL HEART BLOCK; CONNECTIVE TISSUE DISEASE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; HEMATOLOGIC DISEASE; HUMAN; LIVER DISEASE; LUPUS ERYTHEMATOSUS; MORBIDITY; MORTALITY; MYOCARDITIS; NEWBORN DISEASE; PLACENTAL TRANSFER; PREVALENCE; RECURRENCE RISK; REVIEW; SEX RATIO; SJOEGREN SYNDROME; SKIN DEFECT; SYSTEMIC LUPUS ERYTHEMATOSUS; ZYGOSITY; EPIDEMIOLOGY; NEWBORN;

CAUSALITY; HUMANS; INFANT, NEWBORN; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREVALENCE;

EID: 0141955223     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(03)00211-X     Document Type: Review

References (104)

1. Buyon JP. Autoantibodies reactive with Ro(SSA) and La(SSB) and pregnancy. J Rheumatol 1997;24:12-6.
2. Buyon JP. Neonatal lupus syndromes. Curr Opin Rheumatol 1994;6:523-9.
3. Buyon JP. Neonatal lupus: bedside to bench and back. Scand J Rheumatol 1996;25:271-6.
4. Reichlin M, Brucato A, Frank MB, Maddison PJ, McCubbin VR, Wolfson-Reichlin M, et al. Concentration of autoantibodies to native 60-kd Ro/SS-A and denatured 52-kd Ro/SS-A in eluates from the heart of a child who died with congenital complete heart block. Arthritis Rheum 1994;37:1698-703.
5. Morquio L. Sur une maladie infantile et familiale caracté risée par des modifications des pouls, des attaques syncopales et épileptiformes et la mort subite. Arch Med Enfants 1901;4:467-75.
6. Hogg GR. Congenital, acute lupus erythematosus associated with subendocardial fibroelastosis. Report of a case. Am J Clin Pathol 1957;28:648-54.
7. Waltuck J, Buyon JP. Autoantibody-associated congenital heart block: outcome in mothers and children. Ann Intern Med 1994;120:544-51.
8. Buyon JP, Hiebert R, Copel J, Craft J, Friedman D, Katholi M, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998;31:1658-66.
9. Neiman AR, Lee LA, Weston WL, Buyon JP. Cutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry. J Pediatr 2000;137:674-80.
10. Lee LA, Sokol RJ, Buyon JP. Hepatobiliary disease in neonatal lupus: prevalence and clinical characteristics in cases enrolled in a national registry. Pediatrics 2002;109:E11.
11. Press J, Uziel Y, Laxer RM, Luy L, Hamilton RM, Silverman ED. Long-term outcome of mothers of children with complete congenital heart block. Am J Med 1996;100:328-32.
12. Lawrence S, Luy L, Laxer R, Krafchik B, Silverman E. The health of mothers of children with cutaneous neonatal lupus erythematosus differs from that of mothers of children with congenital heart block. Am J Med 2000;108:705-9.
13. Brucato A, Gasparini M, Vignati G, Riccobono S, De Juli E, Quinzanini M, et al. Isolated congenital complete heart block: longterm outcome of children and immunogenetic study. J Rheumatol 1995;22:541-3.
14. Brucato A, Franceschini F, Gasparini M, De Juli E, Ferraro G, Quinzanini M, et al. Isolated congenital complete heart block: longterm outcome of mothers, maternal antibody specificity and immunogenetic background. J Rheumatol 1995;22:533-40.
15. Brucato A, Franceschini F, Buyon JP. Neonatal lupus: long-term outcomes of mothers and children and recurrence rate. Clin Exp Rheumatol 1997;15:467-73.
16. Julkunen H, Eronen M. The rate of recurrence of isolated congenital heart block: a population-based study. Arthritis Rheum 2001;44:487-8.
17. Julkunen H, Eronen M. Long-term outcome of mothers of children with isolated heart block in Finland. Arthritis Rheum 2001;44:647-52.
18. Eronen M, Siren MK, Ekblad H, Tikanoja T, Julkunen H, Paavilainen T. Short- and long-term outcome of children with congenital complete heart block diagnosed in utero or as a newborn. Pediatrics 2000;106:86-91.
19. Kitridou RC. The neonatal lupus syndrome. In: Hahn WAH, editor. Dubois' lupus erythematosus. Lippincott Williams and Wilkins; 2002. p. 1023-35.
20. e édition. In: Kahn MF, Peltier AP, Meyer O, Piette JC, editors. Maladies et syndromes systémiques. Paris: Flammarion-Mé decine Sciences; 2000. p. 131-368bis.
21. Michaelsson M, Engle MA. Congenital complete heart block: an international study of the natural history. Cardiovasc Clin 1972;4:85-101.
22. Siren MK, Julkunen H, Kaaja R. The increasing incidence of isolated congenital heart block in Finland. J Rheumatol 1998;25:1862-4.
23. Brucato A, Frassi M, Franceschini F, Cimaz R, Faden D, Pisoni MP, et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 2001;44:1832-5.
24. Watson RM, Lane AT, Barnett NK, Bias WB, Arnett FC, Provost TT. Neonatal lupus erythematosus. A clinical, serological and immunogenetic study with review of the literature. Medicine (Baltimore) 1984;63:362-78.
25. Herreman G, Galezewski N. Maternal connective tissue disease and congenital heart block. N Engl J Med 1985;312:1329.
26. Ho SY, Esscher E, Anderson RH, Michaelsson M. Anatomy of congenital complete heart block and relation to maternal anti-Ro antibodies. Am J Cardiol 1986;58:291-4.
27. Horsfall AC, Venables PJ, Taylor PV, Maini RN. Ro and La antigens and maternal anti-La idiotype on the surface of myocardial fibres in congenital heart block. J Autoimmun 1991;4:165-76.
28. Alexander E, Buyon JP, Provost TT, Guarnieri T. Anti-Ro/SS-A antibodies in the pathophysiology of congenital heart block in neonatal lupus syndrome, an experimental model. In vitro electrophysiologic and immunocytochemical studies. Arthritis Rheum 1992;35:176-89.
29. Gordon PA, Rosenthal E, Khamashta MA, Hughes GR. Absence of conduction defects in the electrocardiograms of mothers with children with congenital complete heart block. J Rheumatol 2001;28:366-9.
30. Garcia S, Nascimento JH, Bonfa E, Levy R, Oliveira SF, Tavares AV, et al. Cellular mechanism of the conduction abnormalities induced by serum from anti-Ro/SSA-positive patients in rabbit hearts. J Clin Invest 1994;93:718-24.
31. Boutjdir M, Chen L, Zhang ZH, Tseng CE, El-Sherif N, Buyon JP. Serum and immunoglobulin G from the mother of a child with congenital heart block induce conduction abnormalities and inhibit L-type calcium channels in a rat heart model. Pediatr Res 1998;44:11-9.
32. Miranda-Carus ME, Boutjdir M, Tseng CE, DiDonato F, Chan EK, Buyon JP. Induction of antibodies reactive with SSA/Ro-SSB/La and development of congenital heart block in a murine model. J Immunol 1998;161:5886-92.
33. Miranda-Carus ME, Askanase AD, Clancy RM, Di Donato F, Chou TM, Libera MR, et al. Anti-SSA/Ro and anti-SSB/La autoantibodies bind the surface of apoptotic fetal cardiocytes and promote secretion of TNF-alpha by macrophages. J Immunol 2000;165:5345-51.
34. Miranda ME, Tseng CE, Rashbaum W, Ochs RL, Casiano CA, Di Donato F, et al. Accessibility of SSA/Ro and SSB/La antigens to maternal autoantibodies in apoptotic human fetal cardiac myocytes. J Immunol 1998;161:5061-9.
35. Tran HB, Macardle PJ, Hiscock J, Cavill D, Bradley J, Buyon JP, et al. Anti-La/SSB antibodies transported across the placenta bind apoptotic cells in fetal organs targeted in neonatal lupus. Arthritis Rheum 2002;46:1572-9.
36. Tran HB, Ohlsson M, Beroukas D, Hiscock J, Bradley J, Buyon JP, et al. Subcellular redistribution of la/SSB autoantigen during physiologic apoptosis in the fetal mouse heart and conduction system: a clue to the pathogenesis of congenital heart block. Arthritis Rheum 2002;46:202-8.
37. Clancy RM, Askanase AD, Kapur RP, Chiopelas E, Azar N, Miranda-Carus ME, et al. Transdifferentiation of cardiac fibroblasts, a fetal factor in anti-SSA/Ro-SSB/La antibody-mediated congenital heart block. J Immunol 2002;169:2156-63.
38. Buyon JP. Maternal autoantibodies and fetal injury. 66th Annual Scientific Meeting of the American College of Rheumatology., ACR basic symposium, New Orleans, 2002.
39. Meyer O. Le lupus érythémateux néonatal (LENN): vers une meilleure connaissance de la physiopathogénie. Ann Dermatol Venereol 2000;127:799-804.
40. Buyon JP, Winchester RJ, Slade SG, Arnett F, Copel J, Friedman D, et al. Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies. Arthritis Rheum 1993;36:1263-73.
41. Julkunen H, Kaaja R, Siren MK, Mack C, McCready S, Holthofer H, et al. Immune-mediated congenital heart block (CHB): identifying and counseling patients at risk for having children with CHB. Semin Arthritis Rheum 1998;28:97-106.
42. Salomonsson S, Dorner T, Theander E, Bremme K, Larsson P, Wahren-Herlenius M. A serologic marker for fetal risk of congenital heart block. Arthritis Rheum 2002;46:1233-41.
43. Fessel WJ. Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women. Arch Intern Med 1974;134:1027-35.
44. Arnaiz-Villena A, Vazquez-Rodriguez JJ, Vicario JL, Lavilla P, Pascual D, Moreno F, et al. Congenital heart block immunogenetics. Evidence of an additional role of HLA class III antigens and independence of Ro autoantibodies. Arthritis Rheum 1989;32:1421-6.
45. Miyagawa S, Shinohara K, Kidoguchi K, Fujita T, Fukumoto T, Hashimoto K, et al. Neonatal lupus erythematosus: studies on HLA class II genes and autoantibody profiles in Japanese mothers. Autoimmunity 1997;26:95-101.
46. Colombo G, Brucato A, Coluccio E, Compasso S, Luzzana C, Franceschini F, et al. DNA typing of maternal HLA in congenital complete heart block: comparison with systemic lupus erythematosus and primary Sjogren's syndrome. Arthritis Rheum 1999;42:1757-64.
47. Cooley HM, Keech CL, Melny BJ, Menahem S, Morahan G, Kay TW. Monozygotic twins discordant for congenital complete heart block. Arthritis Rheum 1997;40:381-4.
48. Stewart JJ. The female X-inactivation mosaic in systemic lupus erythematosus. Immunol Today 1998;19:352-7.
49. Yazici Y, Onel K, Sammaritano L. Neonatal lupus erythematosus in triplets. J Rheumatol 2000;27:807-9.
50. Cimaz R, Fesslova V, Trespidi L, Van Royen A, Kuis W, Meroni P. Neonatal lupus in triplets: new insights in the pathogenesis of complete congenital heart block. 66th Annual Scientific Meeting of the American College of Rheumatology. New Orleans (October 2002). Arthritis Rheum 2002;46:319.
51. Askanase AD, Friedman DM, Copel J, Dische MR, Dubin A, Starc TJ, et al. Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/La antibodies. Lupus 2002;11:145-51.
52. Saleeb S, Copel J, Friedman D, Buyon JP. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus. Arthritis Rheum 1999;42:2335-45.
53. Schmidt KG, Ulmer HE, Silverman NH, Kleinman CS, Copel JA. Perinatal outcome of fetal complete atrioventricular block: a multicenter experience. J Am Coll Cardiol 1991;17:1360-6.
54. Moak JP, Barron KS, Hougen TJ, Wiles HB, Balaji S, Sreeram N, et al. Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. J Am Coll Cardiol 2001;37:238-42.
55. Nield LE, Silverman ED, Taylor GP, Smallhorn JF, Mullen JB, Silverman NH, et al. Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis. Circulation 2002;105:843-8.
56. Cimaz R, Stramba-Badiale M, Brucato A, Catelli L, Panzeri P, Meroni PL. QT interval prolongation in asymptomatic anti-SSA/Ro-positive infants without congenital heart block. Arthritis Rheum 2000;43:1049-53.
57. Cimaz R, Meroni PL, Brucato A, Fesstova VV, Panzeri P, Goulene K, et al. Concomitant disappearance of electrocardiographic abnormalities and of acquired maternal autoantibodies during the first year of life in infants who had QT interval prolongation and anti-SSA/Ro positivity without congenital heart block at birth. Arthritis Rheum 2003;48:266-8.
58. Gordon PA, Khamashta MA, Hughes GR, Rosenthal E. Increase in the heart rate-corrected QT interval in children of anti-Ro-positive mothers, with a further increase in those with siblings with congenital heart block: comment on the article by Cimaz et al. Arthritis Rheum 2001;44:242-3.
59. Schwartz PJ, Stramba-Badiale M, Segantini A, Austoni P, Bosi G, Giorgetti R, et al. Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med 1998;338:1709-14.
60. Schwartz PJ, Montemerlo M, Facchini M, Salice P, Rosti D, Poggio G, et al. The QT interval throughout the first 6 months of life: a prospective study. Circulation 1982;66:496-501.
61. Southall DP, Richards J, Brown DJ, Johnston PG, de Swiet M, Shinebourne EA. 24-hour tape recordings of ECG and respiration in the newborn infant with findings related to sudden death and unexplained brain damage in infancy. Arch Dis Child 1980;55:7-16.
62. Montague TJ, Taylor PG, Stockton R, Roy DL, Smith ER. The spectrum of cardiac rate and rhythm in normal newborns. Pediatr Cardiol 1982;2:33-8.
63. Alpay F, Celiker A, Lenk MK, Ozcan O, Tanindi S, Isik E. Ambulatory electrocardiographic monitoring in healthy newborn infants. Turk J Pediatr 1993;35:163-70.
64. Luo SF, Huang CC, Wang JW. Neonatal lupus erythematosus: report of a case. Taiwan Yi Xue Hui Za Zhi 1989;88:832-5.
65. Schoenlebe J, Buyon JP, Zitelli BJ, Friedman D, Greco MA, Knisely AS. Neonatal hemochromatosis associated with maternal autoantibodies against Ro/ SS-A and La/SS-B ribonucleoproteins. Am J Dis Child 1993;147:1072-5.
66. Kanagasegar S, Cimaz R, Kurien BT, Brucato A, Scofield RH. Neonatal lupus manifests as isolated neutropenia and mildly abnormal liver functions. J Rheumatol 2002;29:187-91.
67. Wolach B, Choc L, Pomeranz A, Ben Ari Y, Douer D, Metzker A. Aplastic anemia in neonatal lupus erythematosus. Am J Dis Child 1993;147:941-4.
68. Wechsler B, Le Thi Huong D, Vignes B, Piette JC, Chomette G, Godeau P. Toxoplasmosis and lupus. A review of the literature apropos of 4 cases. Ann Med Interne (Paris) 1986;137:324-30.
69. Martin V, Lee LA, Askanase AD, Katholi M, Buyon JP. Long-term followup of children with neonatal lupus and their unaffected siblings. Arthritis Rheum 2002;46:2377-83.
70. Lee LA, Pickrell MB, Reichlin M. Development of complete heart block in an adult patient with Sjogren's syndrome and anti-Ro/SS-A autoantibodies. Arthritis Rheum 1996;39:1427-9.
71. Blanford AT, Murphy BE. In vitro metabolism of prednisolone, dexamethasone, betamethasone, and cortisol by the human placenta. Am J Obstet Gynecol 1977;127:264-7.
72. Buyon JP, Swersky SH, Fox HE, Bierman FZ, Winchester RJ. Intrauterine therapy for presumptive fetal myocarditis with acquired heart block due to systemic lupus erythematosus. Experience in a mother with a predominance of SS-B (La) antibodies. Arthritis Rheum 1987;30:44-9.
73. Shinohara K, Miyagawa S, Fujita T, Aono T, Kidoguchi K. Neonatal lupus erythematosus: results of maternal corticosteroid therapy. Obstet Gynecol 1999;93:952-7.
74. Chua S, Ostman-Smith I, Sellers S, Redman CW. Congenital heart block with hydrops fetalis treated with high-dose dexamethasone; a case report. Eur J Obstet Gynecol Reprod Biol 1991;42:155-8.
75. Knolle P, Mayet W, Lohse AW, Treichel U, Meyer zum Buschenfelde KH, Gerken G. Complete congenital heart block in autoimmune hepatitis (SLA-positive). J Hepatol 1994;21:224-6.
76. Hartikainen-Sorri AL, Kaila J. Systemic lupus erythematosus and habitual abortion. Case report. Br J Obstet Gynaecol 1980;87:729-31.
77. Carreira PE, Gutierrez-Larraya F, Gomez-Reino JJ. Successful intrauterine therapy with dexamethasone for fetal myocarditis and heart block in a woman with systemic lupus erythematosus. J Rheumatol 1993;20:1204-7.
78. Esscher E, Scott JS. Congenital heart block and maternal systemic lupus erythematosus. Br Med J 1979;1:1235-8.
79. Costedoat-Chalumeau N, Amoura Z, Le Thi Hong D, Wechsler B, Vauthier D, Ghillani P, et al. Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block. Ann Rheum Dis 2003 (sous presse).
80. Chico A, Manzanares JM, Halperin I, Martinez de Osaba MJ, Adelantado J, Webb SM. Cushing's disease and pregnancy: report of six cases. Eur J Obstet Gynecol Reprod Biol 1996;64:143-6.
81. Bloom SL, Sheffield JS, McIntire DD, Leveno KJ. Antenatal dexamethasone and decreased birth weight. Obstet Gynecol 2001;97:485-90.
82. Zecca E, Papacci P, Maggio L, Gallini F, Elia S, De Rosa G, et al. Cardiac adverse effects of early dexamethasone treatment in preterm infants: a randomized clinical trial. J Clin Pharmacol 2001;41:1075-81.
83. Doyle LW, Ford GW, Davis NM, Callanan C. Antenatal corticosteroid therapy and blood pressure at 14 years of age in preterm children. Clin Sci (Lond) 2000;98:137-42.
84. Uno H, Lohmiller L, Thieme C, Kemnitz JW, Engle MJ, Roecker EB, et al. Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus. Brain Res Dev Brain Res 1990;53:157-67.
85. Miller WL. Dexamethasone treatment of congenital adrenal hyperplasia in utero: an experimental therapy of unproven safety. J Urol 1999;162:537-40.
86. Lajic S, Wedell A, Bui TH, Ritzen EM, Holst M. Long-term somatic follow-up of prenatally treated children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 1998;83:3872-80.
87. Murphy BP, Inder TE, Huppi PS, Warfield S, Zientara GP, Kikinis R, et al. Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease. Pediatrics 2001;107:217-21.
88. Barrington KJ. The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs. BMC Pediatr 2001;1:1.
89. Baud O, Foix-L'Helias L, Kaminski M, Audibert F, Jarreau PH, Papiemik E, et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 1999;341:1190-6.
90. Baud O, Laudenbach V, Evrard P, Gressens P. Neurotoxic effects of fluorinated glucocorticoid preparations on the developing mouse brain: role of preservatives. Pediatr Res 2001;50:706-11.
91. Kaaja R, Julkunen H. Prevention of recurrence of congenital heart block with intravenous immunoglobulin and corticosteroid therapy: comment on the editorial by Buyon et al. Arthritis Rheum 2003;48:280-1 author reply 281-2.
92. Buyon JP, Kim MY, Copel JA, Friedman DM. Reply. Arthritis Rheum 2003;48:281-2.
93. Batard ML, Sainte-Marie D, Clity E, Belhabri S, Cotellon P, Pradinaud R. Lupus érythémateux néonatal cutané: expression discordante chez des jumelles monozygotes. Ann Dermatol Venereol 2000;127:814-7.
94. Gawkrodger DJ, Beveridge GW. Neonatal lupus erythematosus in four successive siblings born to a mother with discoid lupus erythematosus. Br J Dermatol 1984;111:683-7.
95. Harley JB, Kaine JL, Fox OF, Reichlin M, Gruber B. Ro (SS-A) antibody and antigen in a patient with congenital complete heart block. Arthritis Rheum 1985;28:1321-5.
96. Kaaja R, Julkunen H, Ammala P, Kurki P, Koskimies S. Congenital heart block in one of the HLA identical twins. Eur J Obstet Gynecol Reprod Biol 1993;51:78-80.
97. McCue CM, Mantakas ME, Tingelstad JB, Ruddy S. Congenital heart block in newborns of mothers with connective tissue disease. Circulation 1977;56:82-90.
98. Watson RM, Scheel JN, Petri M, Kan JS, Provost TT, Ratrie 3rd H, et al. Neonatal lupus erythematosus. Report of serological and immunogenetic studies in twins discordant for congenital heart block. Br J Dermatol 1994;130:342-8.
99. Scott JS, Maddison PJ, Taylor PV, Esscher E, Scott O, Skinner RP. Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block. N Engl J Med 1983;309:209-12.
100. Callen JP, Fowler JF, Kulick KB, Stelzer G, Smith SZ. Neonatal lupus erythematosus occurring in one fraternal twin. Serologic and immunogenetic studies. Arthritis Rheum 1985;28:271-5.
101. Solomon BA, Laude TA, Shalita AR. Neonatal lupus erythematosus: discordant disease expression of U1RNP-positive antibodies in fraternal twins-is this a subset of neonatal lupus erythematosus or a new distinct syndrome? J Am Acad Dermatol 1995;32:858-62.
102. Machado MV, Tynan MJ, Curry PV, Allan LD. Fetal complete heart block. Br Heart J 1988;60:512-5.
103. Lawrence N, Bligard CA, Storer J, Courrege ML. Neonatal lupus in twins. South Med J 1989;82:657-60.
104. Shimosegawa M, Akasaka T, Matsuta M. Neonatal lupus erythematosus occurring in identical twins. J Dermatol 1997;24:578-82.